A E Maluish
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 13
- Immune Cell Function and Interaction 8
- Immunotherapy and Immune Responses 4
- Immune Response and Inflammation 3
- T-cell and Retrovirus Studies 2
- Oncology 8
- Cytokine Signaling Pathways and Interactions 3
- Cancer Immunotherapy and Biomarkers 2
- PARP inhibition in cancer therapy 1
- Co-authors
- R B Herberman (3 shared papers)D M Strong (1 shared paper)Tetsuhisa Goto (1 shared paper)R. K. Oldham (3 shared papers)W.J. Halliday (3 shared papers)Stephen A. Sherwin (3 shared papers)William H. Isbister (1 shared paper)Ronald G. Steis (2 shared papers)
- Journals
- The Journal of Immunology (3 papers)Journal of Clinical Investigation (1 paper)Journal of Clinical Oncology (1 paper)Cancer Immunology Immunotherapy (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United StatesAustraliaItaly
In The Last Decade
A E Maluish
16 papers receiving 861 citations
Peers
Comparison fields: 5 of 81
- Immunology 611
- Oncology 268
- Genetics 62
- Hematology 54
- Radiology, Nuclear Medicine and Imaging 108
Countries citing papers authored by A E Maluish
This map shows the geographic impact of A E Maluish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A E Maluish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A E Maluish more than expected).
Fields of papers citing papers by A E Maluish
This network shows the impact of papers produced by A E Maluish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A E Maluish. The network helps show where A E Maluish may publish in the future.
Co-authors
The 25 scholars most cited alongside A E Maluish, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 157 | |
| 2 | 1982 | 128 | |
| 3 | 1988 | 106 | |
| 4 | 1983 | 87 | |
| 5 | 1985 | 87 | |
| 6 | 1974 | 87 | |
| 7 | 1985 | 79 | |
| 8 | 1988 | 61 | |
| 9 | Immunomodulatory properties and toxicity of interleukin 2 in patients with cancer. | 1990 | 50 |
| 10 | 1986 | 33 | |
| 11 | 1974 | 23 | |
| 12 | A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer. | 1984 | 21 |
| 13 | Lymphokine-activated killer cells: culture conditions for the generation of maximal in vitro cytotoxicity in cells from normal donors. | 1987 | 21 |
| 14 | Comparative evaluation of multiple lymphoid and recombinant human interleukin-2 preparations. | 1986 | 15 |
| 15 | A trial of autologous plasma perfusion over protein A in patients with breast cancer. | 1984 | 11 |
| 16 | 1975 | 2 |
About A E Maluish
A E Maluish is a scholar working on Immunology, Oncology, Molecular Biology, Complementary and alternative medicine and Organic Chemistry, having authored 16 papers that have together received 968 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (4 papers), Cytokine Signaling Pathways and Interactions (3 papers), Immune Response and Inflammation (3 papers), T-cell and Retrovirus Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), PARP inhibition in cancer therapy (1 paper) and Hematological disorders and diagnostics (1 paper). The work is most often cited by research in Immunology (611 citations), Oncology (268 citations), Genetics (62 citations), Hematology (54 citations) and Radiology, Nuclear Medicine and Imaging (108 citations). A E Maluish has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include R B Herberman, D M Strong, Tetsuhisa Goto, R. K. Oldham, W.J. Halliday, Stephen A. Sherwin, William H. Isbister, Ronald G. Steis, Paul G. Abrams and James A. Knost. Their work appears in journals such as The Journal of Immunology, Journal of Clinical Investigation, Journal of Clinical Oncology, Cancer Immunology Immunotherapy and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.